SanBio Company Income Statement

Financials in millions JPY. Fiscal year is February - January.

Millions JPY. Fiscal year is Feb - Jan.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '25 Oct 31, 2025	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022	Jan '21 Jan 31, 2021
Selling, General & Admin	1,095	1,159	1,690	1,781	1,665	1,730
Research & Development	2,612	2,357	2,849	6,118	4,955	4,071
Operating Expenses	3,707	3,516	4,539	7,899	6,620	5,801
Operating Income	-3,707	-3,516	-4,539	-7,899	-6,620	-5,801
Interest Expense	-28.37	-8	-10	-26	-44	-48
Interest & Investment Income	2.95	2	2	4	5	8
Currency Exchange Gain (Loss)	-273.03	622	1,746	3,326	1,961	-634
Other Non Operating Income (Expenses)	-176.59	-120	-23	-103	119	-54
EBT Excluding Unusual Items	-4,182	-3,020	-2,824	-4,698	-4,579	-6,529
Gain (Loss) on Sale of Investments	-	-	-	-	-	3,318
Gain (Loss) on Sale of Assets	-	2	33	1	-	-
Asset Writedown	-	-	-3	-	-10	-
Other Unusual Items	9.3	9	252	-	29	-
Pretax Income	-4,173	-3,009	-2,542	-4,697	-4,560	-3,211
Income Tax Expense	-728.45	-127	102	862	117	174
Net Income	-3,444	-2,882	-2,644	-5,559	-4,677	-3,385
Net Income to Common	-3,444	-2,882	-2,644	-5,559	-4,677	-3,385
Shares Outstanding (Basic)	71	69	65	58	52	52
Shares Outstanding (Diluted)	71	69	65	58	52	52
Shares Change (YoY)	4.89%	5.42%	12.78%	11.83%	0.01%	1.31%
EPS (Basic)	-48.26	-41.85	-40.48	-95.98	-90.31	-65.37
EPS (Diluted)	-48.26	-41.85	-40.48	-95.98	-90.31	-65.37
Free Cash Flow	-	-3,607	-4,776	-7,441	-6,588	-5,311
Free Cash Flow Per Share	-	-52.38	-73.11	-128.47	-127.21	-102.56
EBITDA	-3,702	-3,507	-4,525	-7,875	-6,488	-5,727
D&A For EBITDA	5.52	9	14	24	132	74
EBIT	-3,707	-3,516	-4,539	-7,899	-6,620	-5,801

Updated Oct 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.